| 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|
| 营业收入(元) | |||
| 血糖监测及糖尿病管理产品(元) | 44,663,054.63 | 117,491,144.95 | 66,330,935.73 |
| 医用耗材(元) | 22,897,968.61 | 38,362,562.41 | 18,690,123.66 |
| 医用设备(元) | 14,362,810.39 | 20,550,103.16 | 11,093,660.76 |
| 医用试剂(元) | 9,654,371.36 | 21,560,970.93 | 12,418,065.61 |
| 营业成本(元) | |||
| 血糖监测及糖尿病管理产品(元) | 15,635,531.92 | 35,975,737.46 | 19,692,096.30 |
| 医用耗材(元) | 14,474,140.47 | 21,784,608.59 | 10,581,013.49 |
| 医用设备(元) | 10,679,950.82 | 14,325,861.67 | 7,368,335.16 |
| 医用试剂(元) | 6,078,081.17 | 12,295,275.44 | 7,027,388.78 |
| 毛利(元) | |||
| 血糖监测及糖尿病管理产品(元) | 29,027,522.71 | 81,515,407.49 | 46,638,839.43 |
| 医用耗材(元) | 8,423,828.14 | 16,577,953.82 | 8,109,110.17 |
| 医用设备(元) | 3,682,859.57 | 6,224,241.49 | 3,725,325.60 |
| 医用试剂(元) | 3,576,290.19 | 9,265,695.49 | 5,390,676.83 |
| 毛利率(%) | |||
| 血糖监测及糖尿病管理产品(%) | 64.99 | 69.38 | 70.31 |
| 医用耗材(%) | 36.79 | 43.21 | 43.39 |
| 医用设备(%) | 25.64 | 30.29 | 33.58 |
| 医用试剂(%) | 37.04 | 42.97 | 43.41 |
| 收入构成(%) | |||
| 血糖监测及糖尿病管理产品(%) | 48.77 | 59.35 | 61.12 |
| 医用耗材(%) | 25.00 | 19.38 | 17.22 |
| 医用设备(%) | 15.68 | 10.38 | 10.22 |
| 医用试剂(%) | 10.54 | 10.89 | 11.44 |
| 毛利构成(%) | |||
| 血糖监测及糖尿病管理产品(%) | 64.92 | 71.77 | 73.03 |
| 医用耗材(%) | 18.84 | 14.60 | 12.70 |
| 医用设备(%) | 8.24 | 5.48 | 5.83 |
| 医用试剂(%) | 8.00 | 8.16 | 8.44 |